Custom Antibody Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)
Description
The global custom antibody market size was valued at USD 393.30 Million in 2024 , driven by rising demand for personalised medicine across the globe. The market is expected to grow at a CAGR of 12.70% during the forecast period of 2025-2034, with the values likely to rise from USD 1300.06 Million by 2034 .
Custom Antibody: Introduction
Custom antibodies are specifically designed for research or diagnostic purposes. It involves generating antibodies that target specific antigens of interest through immunizing an animal, mostly, a rabbit or a mouse. They can be tailored for various applications like western blotting, ELISA, flow cytometry and other lab techniques. Custom antibodies play a crucial role when the usual antibodies do not meet the needs for a research project.
Global Custom Antibody Market Analysis
The biopharmaceutical industry has seen significant growth in recent years. With focus on biologics, monoclonal antibodies, and personalized medicine to treat chronic diseases like cancer and autoimmune disorders, the custom antibody market demand has grown.
The market growth is driven by the rising technical advancements in the antibody research domain. Numerous companies are expanding their biopharmaceutical division to develop efficient and better solutions for patients. In May 2023, Biosynth acquired United Kingdom based Cambridge Research Biochemicals, an independent producer and custom-made peptide and antibody tools. This acquisition is projected to benefit both United States and Europe population, as the companies aim at generating novel, or complex monoclonal as well as polyclonal antibodies that are not present in catalogs.
China based Biocytogen Pharmaceuticals Co. Ltd. revealed the expansion of their company into two new divisions in August 2023. These divisions are designed to focus on animal models and preclinical services along with development and discovery of new antibody-based drugs for out-licensing and partnerships. Such expansions will play a critical role in catering to the increasing demand for pharmaceuticals and will benefit the custom antibody market value significantly in upcoming years.
Global Custom Antibody Market Segmentation
Custom Antibody Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The United States has dominated the custom antibody market share globally. The market size can be accredited to a well-developed research infrastructure, along with the presence of influential pharmaceutical companies working seamlessly to develop more drugs and therapeutics. Moreover, the advent of artificial intelligence and digitally enabled tools is also helping to make the drug development processes rapid and precise.
In Europe, antimicrobial resistance is a key area of attention amongst researchers. As a result, there is increased attention on adopting new technologies for effective antibody-based drugs. Having prominent research and academic institutions home is anticipated to contribute to contribute to the market growth significantly.
The Asia Pacific region is also poised to witness substantial custom antibody market value growth. Influential economies like India, Japan, Singapore, and China are continuously working towards improving the medical ecosystem. India is experiencing significant development with the launch of government initiatives like PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) along with growing privatisation, which can be considered as a major driver for market growth in the forecast period.
Global Custom Antibody Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Custom Antibody: Introduction
Custom antibodies are specifically designed for research or diagnostic purposes. It involves generating antibodies that target specific antigens of interest through immunizing an animal, mostly, a rabbit or a mouse. They can be tailored for various applications like western blotting, ELISA, flow cytometry and other lab techniques. Custom antibodies play a crucial role when the usual antibodies do not meet the needs for a research project.
Global Custom Antibody Market Analysis
The biopharmaceutical industry has seen significant growth in recent years. With focus on biologics, monoclonal antibodies, and personalized medicine to treat chronic diseases like cancer and autoimmune disorders, the custom antibody market demand has grown.
The market growth is driven by the rising technical advancements in the antibody research domain. Numerous companies are expanding their biopharmaceutical division to develop efficient and better solutions for patients. In May 2023, Biosynth acquired United Kingdom based Cambridge Research Biochemicals, an independent producer and custom-made peptide and antibody tools. This acquisition is projected to benefit both United States and Europe population, as the companies aim at generating novel, or complex monoclonal as well as polyclonal antibodies that are not present in catalogs.
China based Biocytogen Pharmaceuticals Co. Ltd. revealed the expansion of their company into two new divisions in August 2023. These divisions are designed to focus on animal models and preclinical services along with development and discovery of new antibody-based drugs for out-licensing and partnerships. Such expansions will play a critical role in catering to the increasing demand for pharmaceuticals and will benefit the custom antibody market value significantly in upcoming years.
Global Custom Antibody Market Segmentation
Custom Antibody Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
- Others
- Mice
- Rabbit
- Others
- Oncology
- Infectious Diseases
- Neurology
- Stem cells
- Immunology
- Cardiovascular Diseases
- Others
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- CRO
- Hospitals and Clinics
- Others
- Direct Tender
- Third Party Distributors
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The United States has dominated the custom antibody market share globally. The market size can be accredited to a well-developed research infrastructure, along with the presence of influential pharmaceutical companies working seamlessly to develop more drugs and therapeutics. Moreover, the advent of artificial intelligence and digitally enabled tools is also helping to make the drug development processes rapid and precise.
In Europe, antimicrobial resistance is a key area of attention amongst researchers. As a result, there is increased attention on adopting new technologies for effective antibody-based drugs. Having prominent research and academic institutions home is anticipated to contribute to contribute to the market growth significantly.
The Asia Pacific region is also poised to witness substantial custom antibody market value growth. Influential economies like India, Japan, Singapore, and China are continuously working towards improving the medical ecosystem. India is experiencing significant development with the launch of government initiatives like PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) along with growing privatisation, which can be considered as a major driver for market growth in the forecast period.
Global Custom Antibody Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Abcam plc.
- Bio-Rad Laboratories, Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies, LLC.
- Abmart
- Labcorp Drug Development
- LifeSpan BioSciences, Inc.
- GenScript
- Agilent Technologies
- Proteogenix
- Raybiotech, Inc.
- ProSci Incorporated
- Innovagen AB
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Custom Antibody Market Overview
- 3.1 Global Custom Antibody Market Historical Value (2018-2024)
- 3.2 Global Custom Antibody Market Forecast Value (2025-2034)
- 4 Global Custom Antibody Market Landscape
- 4.1 Global Custom Antibody Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Custom Antibody Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 5 Global Custom Antibody Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Custom Antibody Market Segmentation
- 6.1 Global Custom Antibody Market by Product Type
- 6.1.1 Market Overview
- 6.1.2 Monoclonal Antibodies
- 6.1.3 Polyclonal Antibodies
- 6.1.4 Recombinant Antibodies
- 6.1.5 Others
- 6.2 Global Custom Antibody Market by Services
- 6.2.1 Market Overview
- 6.2.2 Antibody Development
- 6.2.3 Antibody Production and Purification
- 6.2.4 Antibody Fragmentation and Labelling
- 6.2.5 Others
- 6.3 Global Custom Antibody Market by Source
- 6.3.1 Market Overview
- 6.3.2 Mice
- 6.3.3 Rabbit
- 6.3.4 Others
- 6.4 Global Custom Antibody Market by Application
- 6.4.1 Market Overview
- 6.4.2 Oncology
- 6.4.3 Infectious Diseases
- 6.4.4 Neurology
- 6.4.5 Stem Cells
- 6.4.6 Immunology
- 6.4.7 Cardiovascular Diseases
- 6.4.8 Others
- 6.5 Global Custom Antibody Market by End User
- 6.5.1 Market Overview
- 6.5.2 Pharmaceutical and Biotechnology Companies
- 6.5.3 Academic and Research Institutes
- 6.5.4 CRO
- 6.5.5 Hospitals and Clinics
- 6.5.6 Others
- 6.6 Global Custom Antibody Market by Distribution Channel
- 6.6.1 Market Overview
- 6.6.2 Direct Tender
- 6.6.3 Third Party Distributors
- 6.6.4 Others
- 6.7 Global Custom Antibody Market by Region
- 6.7.1 Market Overview
- 6.7.2 North America
- 6.7.3 Europe
- 6.7.4 Asia Pacific
- 6.7.5 Latin America
- 6.7.6 Middle East and Africa
- 7 North America Custom Antibody Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Custom Antibody Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Custom Antibody Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Custom Antibody Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Custom Antibody Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Thermo Fisher Scientific Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 Creative Diagnostics
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Abcam plc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 Bio-Rad Laboratories, Inc
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 Kaneka Eurogentec S.A.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 YenZym Antibodies, LLC.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 Abmart
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 Labcorp Drug Development
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 LifeSpan BioSciences, Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 GenScript
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 17.11 Agilent Technologies
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisition
- 17.11.5 Certifications
- 17.12 Proteogenix
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisition
- 17.12.5 Certifications
- 17.13 Raybiotech, Inc.
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisition
- 17.13.5 Certifications
- 17.14 ProSci Incorporated
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisition
- 17.14.5 Certifications
- 17.15 Innovagen AB
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisition
- 17.15.5 Certifications
- 18 Global Custom Antibody Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
